By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Trevena, Inc. 

Berwyn  Pennsylvania    U.S.A.
Phone: n/a Fax: n/a



Drug Discovery

Company News
Trevena, Inc. (TRVN) Appoints Julie H. Mchugh And Barbara Yanni To The Board Of Directors 7/1/2014 11:59:17 AM
Results Of Phase 1b Clinical Trial Comparing Trevena, Inc. (TRVN)’s TRV130 To Morphine Published In The Journal Pain 6/24/2014 10:19:54 AM
Trevena, Inc. (TRVN) Announces Positive Phase 1 Results For TRV734 For Acute And Chronic Pain 6/23/2014 11:37:08 AM
Trevena, Inc. (TRVN) CEO To Present At The 9th Annual JMP Securities Healthcare Conference 6/18/2014 11:28:07 AM
Trevena, Inc. (TRVN) CEO To Present At The Jefferies and Co. 2014 Global Healthcare Conference 5/27/2014 6:47:00 AM
Trevena, Inc. (TRVN) Highlights Phase 2b-BLAST AHF Trial For TRV027 At The European Society Of Cardiology Heart Failure 2014 Meeting 5/19/2014 6:55:04 AM
Trevena, Inc. (TRVN) Appoints John M. Limongelli As General Counsel 5/15/2014 9:40:57 AM
Trevena, Inc. (TRVN) Reports First Quarter 2014 Financial Results 5/9/2014 7:42:21 AM
Trevena, Inc. (TRVN) To Host Conference Call On May 9th To Discuss First Quarter 2014 Financial Results And Recent Highlights 5/2/2014 9:44:05 AM
Trevena, Inc. (TRVN) Initiates Phase 2 Study Of TRV130 In Acute Postoperative Pain 5/1/2014 2:35:02 PM